Instil Bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Instil Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Instil Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.6M, a 64.6% increase year-over-year.
  • Instil Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$74.7M, a 63.2% increase year-over-year.
  • Instil Bio, Inc. annual Operating Income (Loss) for 2023 was -$159M, a 29.7% increase from 2022.
  • Instil Bio, Inc. annual Operating Income (Loss) for 2022 was -$226M, a 45.6% decline from 2021.
  • Instil Bio, Inc. annual Operating Income (Loss) for 2021 was -$156M, a 362% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$74.7M -$23.6M +$43.1M +64.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$118M -$14.1M +$6.85M +32.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$125M -$24M +$34.5M +59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$159M -$13M +$43.8M +77.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$203M -$66.7M -$10.1M -17.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$193M -$21M +$37.7M +64.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$231M -$58.4M -$4.16M -7.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$226M -$56.8M -$3.05M -5.67% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$223M -$56.6M -$13.6M -31.7% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-13
Q2 2022 -$210M -$58.7M -$23.3M -66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$186M -$54.3M -$30.9M -132% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$156M -$53.8M -$36.3M -208% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$119M -$43M -$35.3M -458% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$84M -$35.4M -$30.8M -670% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$53.2M -$23.4M -$19.5M -506% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$33.6M -$17.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$7.71M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$4.59M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.86M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.